China Approves First Domestic 9-Valent HPV Vaccine
China approves its first domestically developed 9-valent HPV vaccine, a major step in public health and medical innovation offering broader protection against cervical cancer.
HPVVaccine
Read More
China Launches First Domestic Nine-Valent HPV Vaccine, Boosting Public Health Efforts
China approves its first domestically developed nine-valent HPV vaccine, enhancing cervical cancer prevention efforts and expanding access to advanced medical solutions.